Document is current
Any future updates will be listed below
-
Authors
Mericskay, Mathias https://orcid.org/0000-0002-6779-092X
Zuurbier, Coert J. https://orcid.org/0000-0001-8361-2448
Heather, Lisa C.
Karlstaedt, Anja
Inserte, Javier
Bertrand, Luc https://orcid.org/0000-0003-0655-7099
Kararigas, Georgios https://orcid.org/0000-0002-8187-0176
Ruiz-Meana, Marisol
Maack, Christoph https://orcid.org/0000-0003-3694-4559
Schiattarella, Gabriele G.
- License Information
-
More Information
Article History
Accepted: 1 May 2025
First Online: 22 June 2025
Competing interests
: C.M. is an advisory board member or speaker for Amgen, AstraZeneca, Bayer, Berlin Chemie, Boehringer Ingelheim, Bristol Myers Squibb, Edwards, Lilly, Novartis, Novo Nordisk and Servier. The other authors declare no competing interests.
